Abstract:Impaired brain energy metabolism and oxidative stress are implicated in cognitive decline and the pathologic accumulations of amyloid β-peptide (Aβ) and hyperphosphorylated tau in Alzheimer's disease (AD). To determine whether improving brain energy metabolism will forestall disease progress in AD, the impact of the β-nicotinamide adenine dinucleotide precursor nicotinamide on brain cell mitochondrial function and macroautophagy, bioenergetics-related signaling, and cognitive performance were studied in cultured neurons and in a mouse model of AD. Oxidative stress resulted in decreased mitochondrial mass, mitochondrial degeneration, and autophagosome accumulation in neurons. Nicotinamide preserved mitochondrial integrity and autophagy function, and reduced neuronal vulnerability to oxidative/metabolic insults and Aβ toxicity. β-Nicotinamide adenine dinucleotide biosynthesis, autophagy, and phosphatidylinositol-3-kinase signaling were required for the neuroprotective action of nicotinamide. Treatment of 3xTgAD mice with nicotinamide for 8 months resulted in improved cognitive performance, and reduced Aβ and hyperphosphorylated tau pathologies in hippocampus and cerebral cortex. Nicotinamide treatment preserved mitochondrial integrity, and improved autophagy-lysosome procession by enhancing lysosome/autolysosome acidification to reduce autophagosome accumulation. Treatment of 3xTgAD mice with nicotinamide resulted in elevated levels of activated neuroplasticity-related kinases (protein kinase B [Akt] and extracellular signal-regulated kinases) and the transcription factor cyclic adenosine monophosphate (AMP) response element-binding protein in the hippocampus and cerebral cortex. Thus, nicotinamide suppresses AD pathology and cognitive decline in a mouse model of AD by a mechanism involving improved brain bioenergetics with preserved functionality of mitochondria and the autophagy system.

NAD+ Can Induce Autophagy of Neuro2a Cells and PC12 Cells

NAD+ Induces Autophagy of Neuro2a Cells by Increasing Oxidative Stress

NAD+ Treatment Induces Delayed Autophagy in Neuro2a Cells Partially by Increasing Oxidative Stress

Nicotinamide Forestalls Pathology and Cognitive Decline in Alzheimer Mice: Evidence for Improved Neuronal Bioenergetics and Autophagy Procession

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

NAD+ Treatment Can Prevent Multiple Rotenone‐induced Apoptotic Changes of PC12 Cells

NAD+ Modulates the Proliferation and Differentiation of Adult Neural Stem/Progenitor Cells via Akt Signaling Pathway

NAD+ Treatment Prevents Rotenone-Induced Apoptosis and Necrosis of Differentiated PC12 Cells

NAD depletion mediates cytotoxicity in human neurons with autophagy deficiency

NAD+ Treatment Can Prevent Rotenone-Induced Increases in DNA Damage, Bax Levels and Nuclear Translocation of Apoptosis-Inducing Factor in Differentiated PC12 Cells

Induction of Autophagy in Neurite Degeneration of Mouse Superior Cervical Ganglion Neurons

NAD+ Treatment Induces Tumor Cell Necrosis by P2X7 Receptor‐Independent Pathways

SIRT2, ERK and Nrf2 Mediate NAD+ Treatment-Induced Increase in the Antioxidant Capacity of PC12 Cells under Basal Conditions

Nadh Can Induce Necrosis of C6 Glioma Cells and Neuro2a Cells

NAD+ Treatment Can Block Rotenone‐induced Nuclear Apoptotic Changes of PC12 Cells

Targeting the autophagy-NAD axis protects against cell death in Niemann-Pick type C1 disease models

Transport of Autophagosomes in Neurites of Pc12 Cells During Serum Deprivation

NAD+ treatment can increase directly the antioxidant capacity of rotenone-treated differentiated PC12 cells

Control of NAD+ homeostasis by autophagic flux modulates mitochondrial and cardiac function

Down-Regulation of Bcl-2 Enhances Autophagy Activation and Cell Death Induced by Mitochondrial Dysfunction in Rat Striatum

NAD(+) Administration Decreases Ischemic Brain Damage Partially by Blocking Autophagy in a Mouse Model of Brain Ischemia.